11/16/2026 | Press release | Distributed by Public on 11/16/2026 16:32
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
On March 27, 2026 (the "Effective Time" or "Closing"), Cyabra Strategy Ltd. ("Legacy Cyabra") and Trailblazer Holdings, Inc. ("Holdings") consummated the business combination (the "Business Combination") as contemplated by a definitive business combination agreement and Holdings changed its name to Cyabra, Inc. (the "Company" or "Cyabra"). As a result, the financial statements of Legacy Cyabra are now the financial statements of the Company. The following discussion and analysis of the financial condition and results of operations should be read together with our condensed consolidated financial statements for the nine and three months ended September 30, 2026 and 2025, and the related notes included elsewhere in this Quarterly Report on Form 10-Q and Legacy Cyabra's audited financial statements for the year ended December 31, 2025 and the related notes incorporated by reference into the Company's Form 8-K filed with the U.S. Securities and Exchange Commission (the "SEC") on March 31, 2026.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 under Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond our control, and which may cause our actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be forward-looking statements. You can identify these forward-looking statements through our use of words such as "may," "can," "anticipate," "assume," "should," "indicate," "would," "believe," "contemplate," "expect," "seek," "estimate," "continue," "plan," "point to," "project," "predict," "could," "intend," "target," "potential" and other similar words and expressions of the future.
There are a number of important factors that could cause the actual results to differ materially from those expressed in any forward-looking statement made by us. These factors include, but are not limited to:
| ● | expectations regarding our strategies and future financial performance, including our future business plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures, and our ability to invest in growth initiatives and pursue acquisition opportunities; |
| ● | the outcome of any legal proceedings that may be instituted against us following the Closing; |
| ● | our ability to successfully integrate and operate as a public company following the Business Combination, including our ability to maintain effective internal controls, comply with reporting obligations, and manage increased legal, regulatory, and compliance costs; | |
| ● | our expectations regarding future revenue growth, contract renewals, customer demand, and the conversion of bookings and annualized recurring revenue into recognized revenue, which are subject to the timing of customer purchasing decisions, contract terms, and revenue recognition requirements; | |
| ● | our ability to recognize the anticipated benefits of the Business Combination; |
| ● | our ability to retain key executives; |
| ● | limited liquidity and trading of our securities; |
| ● | geopolitical risk and changes in applicable laws or regulations; |
| ● | the size of the addressable markets for our products and services; |
| ● | the possibility that we may be adversely affected by other economic, business, and/or competitive factors; |
| ● | our ability to regain compliance with Nasdaq's continued listing requirements and maintain the listing of our common stock on The Nasdaq Stock Market LLC ("Nasdaq"); |
| ● | our ability to obtain additional financing on acceptable terms, including the completion of any pending financing transactions, and our ability to continue as a going concern; and |
| ● | operational risk. |
The foregoing does not represent an exhaustive list of matters that may be covered by the forward-looking statements contained herein or risk factors that we are faced with that may cause our actual results to differ from those anticipated in such forward-looking statements. Please see "Part II-Item 1A-Risk Factors" for additional risks which could adversely impact our business and financial performance.
All forward-looking statements are expressly qualified in their entirety by this cautionary notice. You are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this report or the date of the document incorporated by reference into this report. We have no obligation, and expressly disclaim any obligation, to update, revise or correct any of the forward-looking statements, whether as a result of new information, future events or otherwise. We have expressed our expectations, beliefs and projections in good faith and believe they have a reasonable basis. However, we cannot assure you that our expectations, beliefs or projections will result or be achieved or accomplished.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS OF CYABRA
The following discussion and analysis of Cyabra's financial condition and results of operations should be read in conjunction with Cyabra's consolidated financial statements and the notes related thereto which are included elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors, including those set forth under "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and elsewhere in this Quarterly Report.
Overview
Cyabra is an entity that was formed for the purpose of effecting the Business Combination and now serves as a publicly-traded company. Its wholly owned subsidiary is Legacy Cyabra, an Israeli company that was formed on July 13, 2017. Cyabra uncovers disinformation spread online. Disinformation diminishes trust, creates false or negative narratives and content and sows dissension. Creators of disinformation may be sponsored by foreign governments, competitors, or other third parties with significant resources and access to highly sophisticated generative artificial intelligence tools that generate and spread fake content. They use these tools to create both networks and fake social media accounts to disseminate disinformation, inciting fear, anger and distrust and making us question everything we see or read. These tools make it difficult for the targets of the disinformation, whether they are corporations or public sector agencies, to detect and combat its spread. In many cases, these targets do not have the tools or expertise to effectively identify or counteract the threat. As fake accounts using enhanced AI tools appear more and more authentic, the line between real and fake is disappearing. Cyabra combats disinformation by leveraging advanced artificial intelligence ("AI") and machine learning technologies to monitor and analyze online conversations in real-time. Developed by experts in information warfare, Cyabra's platform collects publicly available data from social media and news sites. The platform applies Cyabra's proprietary algorithms to assess authenticity and sentiment, enabling Cyabra to identify fake accounts, uncover harmful narratives, detect GenAI text and images, and filter between real and fake profiles, helping customers protect their brand reputation and ensure the authenticity of online discourse about them.
Cyabra analyzes patterns typical of fake profiles spreading harmful narratives, tracking the source and spread of information to measure its reach and impact. This comprehensive approach enables customers to understand narratives, discover trends, and identify attempts to influence public opinion, safeguarding public trust and maintaining the integrity of online spaces against long-established disinformation threats as well as newer AI-driven harms.
Components of Operating Results
Revenue
Cyabra offers its technology solution primarily on a software-as-a-service (SaaS) subscription basis under which customers purchase a subscription to access Cyabra's suite of tools through a website hosted by a third-party service provider. Subscriptions are non-refundable and generally have terms ranging from several months to three years. These customers receive access to the website through a secure connection. Certain customers, particularly governmental agencies, may want or need to host Cyabra's application on their own server network. Where appropriate, Cyabra will sell licenses to such customers, which have a term of two to three years, under which the customers have the ability to install the application locally. Other potential customers may want to access Cyabra's tools for a limited purpose or for a limited period of time, such as for tracking the reaction of customers to a promotion or a change in the user's business practices. Other potential users wish to sample the utility of Cyabra's solution before committing to a long-term subscription. For these customers, Cyabra provides managed services, under which a customer pays fees for a report or a package of several reports prepared by Cyabra directly based on agreed-upon criteria using its own in-house resources. Cyabra recognizes revenue from its SaaS and on-premises services ratably over the period in which the services are rendered. Cyabra's customers usually pay for the services in advance for the duration of the subscription or license which are recorded as deferred revenue and recognized ratably over the term of the subscription or license. Revenues relating to managed services are recognized at the point in time at which the deliverable is transferred to the customer.
Legacy Cyabra began offering its application to customers in 2022 and to date has generated limited revenues. Consequently, Cyabra has funded its operations principally through the issuance of equity securities, convertible securities and borrowings. Cyabra's ability to generate significant revenues and achieve profitability depends on its ability to successfully continue to develop and commercialize its application and solutions provided by its applications. As of September 30, 2026, Cyabra had an accumulated deficit of approximately $64.2 million. Cyabra expects to incur significant expenses and operating losses in the future as it grows its business and continues to develop and commercialize its application and solutions provided by its applications. Furthermore, Cyabra expects to incur additional costs associated with operating as a public company. Cyabra will need to generate significant revenues to achieve profitability and may never do so. See "Liquidity and Capital Resources" below for a discussion of our liquidity requirements, financing activities and substantial doubt about our ability to continue as a going concern.
Cost of Revenues
Cost of revenues consists primarily of costs of servers and services, salaries and related personnel expenses and royalties paid to the Israel Innovation Authority. Cyabra expects its cost of revenues to increase as its business grows and it continues to develop and commercialize its application and solutions provided by its applications.
Operating Expenses
Cyabra's current operating expenses consist of research and development expenses, sales and marketing expenses, and general and administrative expenses.
Research and Development Expenses
Cyabra's research and development expenses consist of salaries and related personnel expenses, share-based compensation expenses, software and storage expenses, rental fees, consultants, and other related research and development expenses. Cyabra expenses research and development costs as incurred.
Sales and Marketing Expenses
Sales and marketing expenses consist primarily of salaries and related personnel expenses, as well as share-based compensation expenses, reseller fees and commissions, subcontractors, conferences and exhibitions costs, travel expenses and other sales and marketing costs. Cyabra expects that sales and marketing expenses will increase in the future as Cyabra increases its commercialization efforts.
General and Administrative Expenses
General and administrative expenses consist primarily of professional services, share-based payments expenses, salaries and related expenses, insurance expenses, travel expenses, and other general and administrative expenses. Cyabra expects that general and administrative expenses will increase in the future as Cyabra increases its general and administrative headcount to support the commercialization of its products. Cyabra also expects to incur increased expenses associated with being a public company, including costs of accounting, audit, legal, regulatory and tax compliance services, directors' and officers' insurance, and investor and public relations costs.
Finance Expense and Income
Finance expense and income mainly consist of revaluation of financial liabilities, interest expenses, exchange rate differences and bank fees.
Select Performance Metrics and Non-GAAP Financial Measures
Cyabra uses annualized recurring revenues ("ARR") as a performance metric in managing its business. Cyabra defines ARR as of a specific date as the annualized recurring revenue of signed term-based contracts, including contracts for which services have not yet commenced, from all customers with a term of at least 12 months. ARR is calculated by dividing the total contract value of each signed contract with a term of at least 12 months by the number of years in the term. ARR represents the annualized contract value for all contractually binding term-based contracts at the end of a period. Management uses ARR to understand customer trends and the overall health of Cyabra's business, helping it to formulate strategic business decisions.
ARR is not defined in accounting principles generally accepted in the United States ("GAAP") and is not derived from GAAP measure. ARR should be viewed independently of revenue and deferred revenue and is not intended to be combined with or to replace either of those items. ARR is not a forecast and the active contracts at the end of a reporting period used in calculating ARR may or may not be extended or renewed by our customers. ARR does not represent revenue recognized during a particular period or cash expected to be received during any particular period, and actual revenue recognized under the contracts included in ARR may differ from the amounts reflected in ARR as a result of contract terms, the timing of performance obligations and other factors.
The metrics Cyabra uses to evaluate its business are periodically reviewed and revised to reflect changes in its business. Because Cyabra commenced offering its application in 2022, is still developing and implementing its commercial business strategy and is at an early stage of its commercial operations, it does not believe that metrics related to customer retention or renewals are reliable metrics on which to measure its performance and management does not use such metrics to manage Cyabra's business. Such metrics may become relevant once Cyabra has a longer history of performance.
In addition, we believe that non-GAAP financial measures provide useful information to investors and others in understanding and evaluating our operating results in the same manner as management. As these measures are not financial measures calculated in accordance with GAAP, they should not be considered as substitutes for financial measures that have been calculated in accordance with GAAP. We primarily review the following non-GAAP measures when assessing our performance:
Adjusted EBITDA
In addition to our financial results determined in accordance with GAAP, we believe that adjusted earnings before interest, taxes, depreciation, and amortization ("Adjusted EBITDA"), as a non-GAAP measure, is useful in evaluating our operating performance. We define Adjusted EBITDA as net loss before depreciation and amortization, income taxes, net finance expenses and income, stock-based compensation expenses, non-recurring expenses related to the Business Combination and certain other non-operating gains. We use Adjusted EBITDA to evaluate our ongoing operations. We believe that this non-GAAP financial measure, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations or outlook. In particular, we believe that the use of Adjusted EBITDA is helpful to our investors as it is a metric used by management in assessing our operating performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. In particular, Adjusted EBITDA excludes stock-based compensation expense, which has been, and is expected to continue to be, a significant recurring expense and an important component of our compensation arrangements. Adjusted EBITDA also does not reflect our cash requirements for capital expenditures or working capital needs. In addition, other companies, including companies in our industry, may calculate similarly titled non-GAAP measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measure as a tool for comparison. A reconciliation is provided below for our non-GAAP financial measure to the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review the related GAAP financial measure and the reconciliation of this non-GAAP financial measure to its most directly comparable GAAP financial measure, and not to rely on any single financial measure to evaluate our business.
Adjusted EBITDA
|
Nine Months Ended September 30, |
Three Months Ended September 30, |
|||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
|
USD Thousands |
USD Thousands |
USD Thousands |
USD Thousands |
|||||||||||||
| Net loss | (16,801 | ) | (8,501 | ) | (2,592 | ) | (2,741 | ) | ||||||||
| Depreciation and amortization | 46 | 42 | 17 | 13 | ||||||||||||
| Income taxes | 65 | 20 | 1 | 1 | ||||||||||||
| Finance expenses (income), net | (794 | ) | (1,134 | ) | 5 | 582 | ||||||||||
| EBITDA | (17,484 | ) | (9,573 | ) | (2,569 | ) | (2,145 | ) | ||||||||
| Stock based compensation expenses (1) | 6,146 | 2,703 | 706 | 448 | ||||||||||||
| Non-recurring expenses related to the Business Combination (2) | 3,438 | - | - | - | ||||||||||||
| Other non-operating gain (3) | (631 | ) | - | (631 | ) | - | ||||||||||
| Adjusted EBITDA | (8,531 | ) | (6,870 | ) | (2,494 | ) | (1,697 | ) | ||||||||
| (1) | Represents non-cash charges associated with stock-based compensation expense, which has been, and will continue to be for the foreseeable future, a significant recurring expense in our business and an important part of our compensation strategy. |
| (2) | Represents non-recurring costs related to our Business Combination, including bonus expenses to several employees in connection with the Business Combination. |
| (3) | Represents non-operating gain on settlement of accounts payable. |
Critical Accounting Policies
Cyabra's consolidated financial statements are prepared in accordance with GAAP and have been prepared on a going concern basis. However, as described under "Liquidity and Capital Resources," substantial doubt exists about our ability to continue as a going concern.
Our significant accounting policies are described in the notes to our condensed consolidated financial statements and in our audited consolidated financial statements for the year ended December 31, 2025. There have been no material changes to our critical accounting estimates during the nine months ended September 30, 2026, except as otherwise disclosed in the accompanying financial statements.
The preparation of financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
Information about assumptions made by Cyabra with respect to the future and other reasons for uncertainty with respect to estimates that have a significant risk of resulting in a material adjustment to carrying amounts of assets and liabilities in the next financial year are included in Cyabra's financial statements and accompanying notes.
Results of Operations
Comparison of the nine months ended September 30, 2026 to the nine months ended September 30, 2025
The following table summarizes Cyabra's results of operations for the nine months ended September 30, 2026 and 2025:
|
Nine Months Ended September 30, |
||||||||
| 2026 | 2025 | |||||||
|
USD Thousands |
USD Thousands |
|||||||
| Revenues | 5,271 | 4,078 | ||||||
| Cost of revenues | 800 | 584 | ||||||
| Gross profit | 4,471 | 3,494 | ||||||
| Operating costs and expenses | ||||||||
| Research and development expenses | 9,742 | 5,347 | ||||||
| Sales and marketing expenses | 3,991 | 4,443 | ||||||
| General and administrative expenses | 8,899 | 3,319 | ||||||
| Total operating loss | 18,161 | 9,615 | ||||||
| Financing income, net | (794 | ) | (1,134 | ) | ||||
| Other Income | (631 | ) | - | |||||
| Loss before taxes on income | 16,736 | 8,481 | ||||||
| Taxes on Income | 65 | 20 | ||||||
| Net loss for the period | 16,801 | 8,501 | ||||||
Revenues
Revenues for the nine months ended September 30, 2026 were approximately $5.3 million, an increase of approximately $1.2 million, or 29%, compared to approximately $4.1 million for the nine months ended September 30, 2025. The increase in revenues was primarily attributable to new customers who contributed approximately $1.9 million for the nine months ended September 30, 2026, partially offset by a net decrease of approximately $0.7 million in revenues from other customers, including customers that did not renew their contracts in 2026.
ARR
Cyabra's ARR was approximately $8.3 million as of September 30, 2026, compared to approximately $6.7 million as of September 30, 2025, an increase of approximately $1.6 million, or 24%. The increase in ARR was primarily attributable to new customer contracts signed during the twelve months ended September 30, 2026. The increase in ARR reflects the Company's growing base of recurring customer contracts and may contribute to higher revenues in future periods, subject to the terms and performance of the underlying contracts.
Cost of Revenues
Cost of revenues for the nine months ended September 30, 2026 was approximately $0.8 million, an increase of approximately $0.2 million, or 37%, compared to approximately $0.6 million for the nine months ended September 30, 2025. The increase in cost of revenues resulted primarily from the growth in revenues.
Gross Profit
Gross profit for the nine months ended September 30, 2026 was approximately $4.5 million, an increase of approximately $1.0 million, or 28%, compared to approximately $3.5 million for the nine months ended September 30, 2025. The increase resulted primarily from an increase in our revenues.
Research and Development Expenses
Research and development expenses for the nine months ended September 30, 2026 were approximately $9.7 million, an increase of approximately $4.4 million, or 82%, compared to approximately $5.3 million for the nine months ended September 30, 2025. The increase resulted primarily from an increase in share-based payment expenses and payroll and related personnel expenses of $3.9 million, mainly as a result of expenses related to the closing of the Business Combination, as well as an increase in software expenses.
Sales and Marketing Expenses
Sales and marketing expenses for the nine months ended September 30, 2026 were approximately $4.0 million, a decrease of approximately $0.4 million, or 10%, compared to approximately $4.4 million for the nine months ended September 30, 2025. The decrease resulted primarily from a decrease in share-based payment expenses and lower marketing expenses as a result of a lower level of marketing activities in the nine months ended September 30, 2026, as well as lower travel expenses.
General and Administrative Expenses
General and administrative expenses for the nine months ended September 30, 2026 were approximately $8.9 million, an increase of approximately $5.6 million, or 168%, compared to approximately $3.3 million for the nine months ended September 30, 2025. The increase resulted primarily from an increase in professional services expenses, as well as payroll and related personnel expenses and share-based payment expenses, primarily related to the closing of the Business Combination.
Operating Loss
Operating loss for the nine months ended September 30, 2026 was approximately $18.2 million, an increase of approximately $8.6 million, or 89%, compared to approximately $9.6 million for the nine months ended September 30, 2025, primarily as a result of share-based payment expenses and payroll and related personnel expenses, as well as an increase in professional services expenses mainly in relation to the Business Combination.
Finance Expense and Income
Finance income for the nine months ended September 30, 2026 was approximately $0.8 million, a decrease of approximately $0.3 million, or 30%, compared to finance income of approximately $1.1 million for the nine months ended September 30, 2025. The decrease in finance income was primarily attributable to an increase in interest expenses, as well as a decrease in non-cash gains recognized from the remeasurement of financial liabilities measured at fair value during the period, partially offset by exchange rate changes.
Other Income
Other income for the nine months ended September 30, 2026 was approximately $0.6 million, compared to none for the nine months ended September 30, 2025. Other income consisted of a non-recurring gain on settlement of accounts payable.
Total Loss
Total loss for the nine months ended September 30, 2026 was approximately $16.8 million, an increase of approximately $8.3 million, or 98%, compared to approximately $8.5 million for the nine months ended September 30, 2025. The increase in total loss was primarily as a result of an increase in share-based payment expenses and in payroll and related personnel expenses, as well as a one-time non-recurring expense of $3.4 million related to the Business Combination.
Comparison of the three months ended September 30, 2026 to the three months ended September 30, 2025
The following table summarizes Cyabra's results of operations for the three months ended September 30, 2026 and 2025:
|
Three Months Ended September 30, |
||||||||
| 2026 | 2025 | |||||||
|
USD Thousands |
USD Thousands |
|||||||
| Revenues | 2,003 | 1,487 | ||||||
| Cost of revenues | 304 | 175 | ||||||
| Gross profit | 1,699 | 1,312 | ||||||
| Operating costs and expenses | ||||||||
| Research and development expenses | 2,174 | 1,657 | ||||||
| Sales and marketing expenses | 1,432 | 1,250 | ||||||
| General and administrative expenses | 1,310 | 563 | ||||||
| Total operating loss | 3,217 | 2,158 | ||||||
| Financing expenses, net | 5 | 582 | ||||||
| Other income | (631 | ) | - | |||||
| Loss before taxes on income | 2,591 | 2,740 | ||||||
| Taxes on Income | 1 | 1 | ||||||
| Net loss for the period | 2,592 | 2,741 | ||||||
Revenues
Revenues for the three months ended September 30, 2026 were approximately $2.0 million, an increase of approximately $0.5 million, or 35%, compared to approximately $1.5 million for the three months ended September 30, 2025. The increase in revenues was primarily attributable to new customers that contributed approximately $0.3 million in revenues during the three months ended September 30, 2026, as well as increased revenue recognized from existing customers, partially offset by a decrease in revenues from customers that did not renew their contracts in 2026.
Cost of Revenues
Cost of revenues for the three months ended September 30, 2026 was approximately $0.3 million, an increase of approximately $0.1 million or 74% compared to approximately $0.2 million for the three months ended September 30, 2025. The increase in cost of sales resulted primarily from the growth in revenues.
Gross Profit
Gross profit for the three months ended September 30, 2026 was approximately $1.7 million, an increase of approximately $0.4 million, or 29%, compared to approximately $1.3 million for the three months ended September 30, 2025. The increase in gross profit resulted from an increase in our revenues.
Research and Development Expenses
Research and development expenses for the three months ended September 30, 2026 were approximately $2.2 million, an increase of approximately $0.5 million, or 31%, compared to approximately $1.7 million for the three months ended September 30, 2025. The increase in research and development expenses resulted primarily from an increase in payroll and related personnel expenses, an increase in research and development software and storage costs, as well as an increase in share-based payment expenses.
Sales and Marketing Expenses
Sales and marketing expenses for the three months ended September 30, 2026 were approximately $1.4 million, an increase of approximately $0.1 million, or 15%, compared to approximately $1.3 million for the three months ended September 30, 2025. The increase in sales and marketing expenses resulted primarily from an increase in subcontractor expenses and in share-based payment expenses.
General and Administrative Expenses
General and administrative expenses for the three months ended September 30, 2026 were approximately $1.3 million, an increase of approximately $0.7 million, or 133%, compared to approximately $0.6 million for the three months ended September 30, 2025. The increase in general and administrative expenses resulted primarily from an increase in professional services, insurance expenses, as well as an increase in share-based payment expenses, travel expenses and payroll and related personnel expenses.
Operating Loss
Operating loss for the three months ended September 30, 2026 was approximately $3.2 million, an increase of approximately $1.0 million, or 49%, compared to approximately $2.2 million for the three months ended September 30, 2025. The increase in operating loss resulted primarily from the increase in professional services expenses, payroll and related personnel expenses and share-based payment expenses as well as an increase in research and development software and storage, and sales and marketing subcontractors expenses, partially offset by the increase in gross profit.
Finance Expense and Income
Finance expenses for the three months ended September 30, 2026 were approximately $0.005 million, a decrease of approximately $0.6 million, or 99%, compared to finance expenses of approximately $0.6 million for the three months ended September 30, 2025. The decrease in finance expenses was primarily attributable to exchange rate differences and remeasurement of financial liabilities measured at fair value, both of which resulted in income in the three months ended September 30, 2026, compared to expenses in the corresponding period, as well as a decrease in interest expenses.
Other Income
Other income for the three months ended September 30, 2026 was approximately $0.6 million, compared to none for the three months ended September 30, 2025, and consisted of the non-recurring gain on settlement of accounts payable described above.
Total Loss
Total loss for the three months ended September 30, 2026 was approximately $2.6 million, a decrease of approximately $0.1 million, or 5%, compared to approximately $2.7 million for the three months ended September 30, 2025. The decrease in total loss was primarily from an increase in gross profit, decrease in finance expenses and an increase in other income partially offset by an increase in operating expenses.
Liquidity and Capital Resources
Since our inception through September 30, 2026, we have funded our operations principally through the issuances of equity securities and borrowings. As of September 30, 2026, our cash and cash equivalents were approximately $1.3 million. As of September 30, 2026, we had current assets of approximately $2.4 million and current liabilities of approximately $10.9 million, resulting in a working capital deficit of approximately $8.5 million. We also had a total stockholders' deficit of approximately $8.5 million as of September 30, 2026.
The table below presents our cash flows for the nine-month periods ended September 30, 2026 and September 30, 2025:
|
Nine months ended September 30, 2026 |
Nine months ended September 30, 2025 |
|||||||
| USD Thousands | USD Thousands | |||||||
| Operating Activities | (9,567 | ) | (6,525 | ) | ||||
| Investing Activities | (41 | ) | (47 | ) | ||||
| Financing Activities | 10,710 | 5,627 | ||||||
| Net increase (decrease) in cash | 1,102 | (945 | ) | |||||
Operating Activities
Net cash used in operating activities was approximately $9.6 million during the nine months ended September 30, 2026, compared to approximately $6.5 million during the nine months ended September 30, 2025. The increase in net cash used in operating activities was primarily attributable to an increase in net loss of approximately $8.3 million, partially offset by the combined effect of non-cash expenses and changes in working capital of approximately $5.2 million, mainly related to share-based payments, including share-based payments for advisory services and shares issued to advisors in connection with the Business Combination.
Investing Activities
Net cash used in investing activities was approximately $0.04 million during the nine months ended September 30, 2026, compared to approximately $0.05 million during the nine months ended September 30, 2025.
Financing Activities
Net cash provided by financing activities was approximately $10.7 million during the nine months ended September 30, 2026, compared to approximately $5.6 million during the nine months ended September 30, 2025. The increase in net cash provided by financing activities resulted primarily from net proceeds from private investment in public equity (PIPE) transactions and cash received upon the closing of the Business Combination during the nine months ended September 30, 2026. These were partially offset by an increase in repayment of loans and a decrease in proceeds from loans compared to the nine months ended September 30, 2025.
Cyabra will need to raise additional capital to support its operations until such time, if any, as it is able to generate sufficient cash to fund its working capital requirements. Cyabra may not be able to obtain additional financing on acceptable terms, or at all. To the extent that Cyabra raises additional capital through the future sale of equity or debt, the ownership interest of its shareholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of Cyabra's existing shareholders. If Cyabra raises additional funds through partnerships or strategic alliances in the future, it may have to relinquish valuable rights to its technologies, future revenue streams or products or grant licenses on terms that may not be favorable to Cyabra.
On July 9, 2026, Cyabra entered into securities purchase agreements (each, a "Purchase Agreement") with accredited investors relating to an offering (the "Offering") and the sale of an aggregate of 1,175,090 shares (the "Shares") of common stock, pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 12,643,680 shares of common stock (the "Pre-Funded Warrant Shares"), at a purchase price of $0.435 per Share and $0.4349 per Pre-Funded Warrant, Series A warrants (the "Series A Common Warrants") to purchase up to 13,818,770 shares of common stock (the "Series A Common Warrant Shares"), at an exercise price of $0.50 and Series B warrants (the "Series B Common Warrants") to purchase up to 13,818,770 shares of common stock (the "Series B Common Warrant Shares"), at an exercise price of $0.45. The Offering closed on July 10, 2026. The gross proceeds from the Offering, before deducting the placement agent fees and offering expenses, were approximately $6 million.
The Pre-Funded Warrants are exercisable immediately upon issuance and remain exercisable until exercised in full. The Series A Common Warrants became exercisable on September 2, 2026, the date stockholder approval (the "Stockholder Approval") was obtained, and will expire five years from that date. The Series B Common Warrants became exercisable on September 2, 2026 and will expire twelve months from that date.
In conjunction with the Offering, Cyabra engaged A.G.P./Alliance Global Partners, as exclusive placement agent and agreed to pay the placement agent a cash fee equal to 7.0% of the aggregate gross proceeds raised from the sale of the securities sold in the Offering, and agreed to reimburse the placement agent for accountable legal fees and other reasonable and documented out-of-pocket expenses incurred in connection with the transaction in the amount of up to $75,000 and the reimbursement of up to $15,000 for non-accountable expenses.
On July 9, 2026, Cyabra entered into an exchange agreement (the "Exchange Agreement") with Alpha Capital Anstalt (the "Holder") that holds the outstanding Series C Convertible Preferred Stock ("Series C Preferred Shares"), pursuant to which the Holder agreed to exchange at the Exchange Closing (as defined in the Exchange Agreement) an amount of Series C Preferred Shares with an aggregate value of $10,660,000 (the "Preferred Shares Value"), and Cyabra agreed to issue to the Holder, in the exchange therefor: (i) the number of shares of Common Stock; (ii) if applicable, the Pre-Funded Warrants; and (iii) the Series A Common Warrants and the Series B Common Warrants (including the Series A Common Warrant Shares and the Series B Common Warrant Shares) as if the Holder had invested additional cash equal to the Preferred Shares Value in the Offering. Upon the Exchange Closing, the Exchange Preferred Shares (as defined in the Exchange Agreement) were automatically cancelled, retired and restored to the status of authorized but unissued shares of Series C Preferred Shares.
On July 9, 2026, Cyabra entered into a conversion agreement (the "Conversion Agreement") with the holders (the "Holders") of an aggregate of 15,507 shares of Series A Preferred Shares and Series B Convertible Preferred Stock ("Series B Preferred Shares" and together with the Series A Preferred Shares, the "Preferred Shares"), convertible into an aggregate of 35,648,276 shares of common stock at the reduced conversion price described below, pursuant to which the Holders agreed that upon the Conversion Closing (as defined in the Conversion Agreement), all of the outstanding Preferred Shares (the "Committed Preferred Shares") would be deemed to have been converted (the "Conversion") into shares of Common Stock (or pre-funded warrants in lieu thereof). Pursuant to the Conversion Agreement, Cyabra and the Holders agreed to amend the terms of the Certificates of Designation governing the Preferred Shares to reduce the conversion price of each class of Preferred Shares to $0.435 per share.
On September 2, 2026, Cyabra's stockholders approved the Conversion and the Exchange. The Conversion Closing and the Exchange Closing occurred on September 9, 2026, upon which all outstanding Series A Preferred Shares, Series B Preferred Shares and Series C Preferred Shares were converted into, or exchanged for, shares of Common Stock, Pre-Funded Warrants, Series A Common Warrants and Series B Common Warrants. As of September 30, 2026, no preferred shares were outstanding.
If Cyabra is unable to raise additional funds when needed, Cyabra may be required to delay, limit, reduce or terminate its product development or future commercialization efforts.
In connection with Cyabra's assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standard Board Accounting Standards Update 2014-15, "Disclosures of Uncertainties about an Entity's Ability to Continue as a Going Concern," management has determined that Cyabra currently lacks the liquidity it needs to sustain operations for a reasonable period of time, which is considered to be at least one year from the date that the financial statements are issued as it expects to continue to incur significant costs. There are no assurances however, that Cyabra will be successful in obtaining the level of financing needed for its operations. If Cyabra is unsuccessful in commercializing its products and securing sufficient funding, it may need to reduce activities, curtail, or even cease operations. The consolidated financial statements do not include any adjustments relating to the carrying amounts and classification of assets, liabilities, and reported expenses that might be necessary should Cyabra be unable to continue as a going concern.
Nasdaq Listing Compliance
The Company has previously received notices from the Listing Qualifications Department of Nasdaq indicating that the Company does not comply with the continued listing requirements of the Nasdaq Global Market relating to (i) the minimum market value of listed securities, (ii) the minimum market value of publicly held shares and (iii) the minimum bid price of its common stock.
In response to these deficiencies, the Company has been evaluating available alternatives to regain compliance.
As previously disclosed, on June 9, 2026, the Company received a notice from the Listing Qualifications Staff ("Staff") of The Nasdaq Stock Market ("Nasdaq") that based on its Market Value of Listed Securities ("MVLS") for the period from March 27, 2026 through May 12, 2026, the Company no longer met the continued listing requirement of Nasdaq under Listing Rule 5450(b)(2)(A), to maintain a minimum MVLS of $50,000,000. In accordance with Listing Rule 5810(c)(3)(C), Nasdaq provided the Company with a compliance period of 180 calendar days, or until November 9, 2026, in which to regain compliance with Nasdaq continued listing requirement.
On November 16, 2026, the Company received a letter (the "Delist Determination Letter") from Staff notifying that it had not regained compliance with MVLS Nasdaq rule. Accordingly, its securities will be delisted from The Nasdaq Global Market. In that regard, unless the Company requests an appeal of this determination by November 23, 2026, trading of the Company's securities will be suspended at the opening of business on November 25, 2026, and a Form 25-NSE will be filed with the Securities and Exchange Commission, which will remove the Company's securities from listing and registration on The Nasdaq Stock Market. The Company intends to timely submit its hearing request, which will stay the suspension.
The Company also remains subject to non-compliance with (i) Nasdaq Listing Rule 5450(b)(2)(C) due to its failure to maintain a minimum Market Value of Publicly Held Shares, or MVPHS, of $15 million, and (ii) Nasdaq Listing Rule 5450(a)(1) due to the failure of its common stock to maintain a minimum bid price of $1.00 per share for the 30 consecutive business days ended June 8, 2026. In accordance with Nasdaq Listing Rule 5810(c)(3)(D), we have a compliance period of 180 calendar days from the date of the notice, or until December 7, 2026, and we may regain compliance if at any time during the compliance period the MVPHS closes at $15 million or more for a minimum of ten consecutive business days. In addition, in accordance with Nasdaq Listing Rule 5810(c)(3)(A), we have been provided a compliance period of 180 calendar days, or until December 7, 2026, in which to regain compliance with the minimum bid price rule.
There can be no assurance that the Company will regain compliance with the minimum bid price requirement within any applicable compliance period. If the Company is unable to maintain its Nasdaq listing, the liquidity and market price of its common stock and its ability to raise additional capital could be materially adversely affected.
Reverse Stock Split
In connection with the Company's efforts to regain compliance with Nasdaq's minimum bid price requirement, the Company's Board of Directors has approved a reverse stock split of the Company's outstanding common stock at a ratio of 1-for-30, subject to stockholder approval. The proposed reverse stock split was approved at the Company's annual meeting of stockholders on November 10, 2026.
There can be no assurance that the reverse stock split will be implemented or that it will result in the Company regaining or maintaining compliance with Nasdaq's minimum bid price requirement.
Subsequent Financing Transactions
On November 15, 2026, the Company entered into a Securities Purchase Agreement (the "Securities Purchase Agreement") with Alpha Capital Anstalt and certain other purchasers, pursuant to which the Company agreed to issue and sell shares of newly designated Series D Convertible Preferred Stock (the "Series D Preferred Stock") and warrants to purchase shares of the Company's common stock (the "Warrants") in a private placement offering for aggregate consideration of up to approximately $45.6 million. The Series D Preferred Stock will have a stated value of $1,000 per share and will be convertible into common stock at an initial conversion price of $0.15 per share, subject to adjustment. The Warrants will have an initial exercise price of $0.15 per share, subject to adjustment, and will become exercisable following receipt of the required stockholder approval. The initial closing is expected to involve an aggregate subscription amount of approximately $15.6 million, consisting of $10 million in new investment and approximately $5.6 million in subscription consideration to be satisfied through the cancellation of approximately $2.8 million of outstanding indebtedness of the Company, including certain obligations originally owed to Loeb & Loeb LLP that were assigned to Alpha Capital Anstalt on November 2, 2026. The initial closing is subject to certain conditions, including required stockholder approvals and confirmation from Nasdaq that the Company has cured its listing deficiencies and that its continued listing has been approved. As of the date of this Quarterly Report on Form 10-Q, the initial closing has not occurred.
The Securities Purchase Agreement also provides for potential additional investments of up to $30 million over a three-year period, subject to the terms and conditions set forth therein. There can be no assurance that any such additional investments will occur or that the initial closing will be consummated.
On November 9, 2026, the Company entered into a Secured Promissory Note and Security Agreement (the "Note Agreement") with Alpha Capital Anstalt (the "Lender"), pursuant to which the Lender agreed to provide financing to the Company in an aggregate principal amount of up to $1.5 million, to be funded in tranches mutually agreed upon by the Company and the Lender. An initial tranche in the principal amount of $650,000 was funded on November 9, 2026.
The outstanding principal amount under the Note Agreement bears interest at a rate of 10% per annum, increasing to the lesser of 18% per annum or the maximum rate permitted by applicable law upon the occurrence and during the continuance of an event of default. The outstanding principal amount, together with accrued interest, is due on January 15, 2027, subject to the Lender's right to extend the maturity date in three-month increments through December 31, 2028.
The Company's obligations under the Note Agreement are secured by a security interest in substantially all of the Company's assets, including certain intellectual property and equity interests in its subsidiaries, subject to certain exceptions and required consents, including with respect to assets subject to restrictions imposed by the Israel Innovation Authority.
The Note Agreement contains customary representations, warranties, covenants and events of default. Upon an event of default, the outstanding principal amount becomes immediately due and payable, and the Lender may exercise its rights and remedies as a secured creditor.
Off-Balance Sheet Arrangements
Cyabra did not have any off-balance sheet arrangements as of September 30, 2026.